On World TB Day 2022 (March 24, 2022), we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB. Read about some of the work being done by Drs. Kevin Schwartzman, Dick Menzies and Faiz Ahmad Khan and others. These researchers are looking into solutions to change the above realities and progress towards the WHO goal of a world free of TB by 2030.
Drs. Kevin Schwartzman and Faiz Ahmad Khan found that screening for active and latent tuberculosis in communities with high TB rates was cost-effective, and recommended it to help reduce outbreaks. Dr. Faiz Ahmad Khan is leading research on AI programs to improve TB detection and his publications are informing new WHO guidelines on this novel technology. Dr. Dick Menzies and his group are conducting studies to find shorter, safer and more effective treatments for latent TB infection (TB prevention) and active TB disease. Dr. Menzies has also spearheaded new evidence-based guidelines for TB prevention and care in Canada.
About our TB Researchers
Dr. Dick Menzies is the director of the McGill International TB Centre and the McGill-WHO Collaborating Centre for TB Research, holds a Canada Research Chair in TB Research (Tier 1) and is a member of the RESP program at the RI-MUHC, associate member of the Meakins-Christie Laboratories and member of the RECRU at McGill University.
Dr. Kevin Schwartzman is the director of the Division of Respiratory Medicine at the McGill University Health Centre (MUHC) and Senior Scientist in the Translational Research in Respiratory Diseases Program at the RI-MUHC. He is an associate member of the Meakins-Christie Laboratories and member of the RECRU at McGill University.
Dr. Faiz Ahman Khan is a respirologist at the MUHC and associate director of the McGill International TB Centre, an associate member of the Meakins-Christie Laboratories and member of the RECRU at McGill University.
Read more
TB and COVID-19, a joint battle? RI-MUHC News. March 24, 2022